4//SEC Filing
Zuraw Qing Che 4
Accession 0001415889-25-020551
CIK 0001817229other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:03 PM ET
Size
7.5 KB
Accession
0001415889-25-020551
Insider Transaction Report
Form 4
Zuraw Qing Che
Chief Development Officer
Transactions
- Award
Common Stock
2025-07-17+937,080→ 937,080 total - Award
Employee Stock Option (right to buy)
2025-07-17+4,373,040→ 4,373,040 totalExercise: $2.38Exp: 2035-07-16→ Common Stock (4,373,040 underlying)
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on August 1, 2026, with the remainder vesting in substantially equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
- [F2]1/4th of the shares underlying the option vest on July 17, 2026, with the remainder vesting in substantially equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0002079210
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:03 PM ET
- Size
- 7.5 KB